About FDA
Number of cases referred to Office of Enforcement for debarment action
Dictionary: Number of OCI criminal convictions completed during the reported month and referred to OE for the exclusive purpose of identifying potential candidates for debarment. The mission of OCI is to investigate suspected criminal violations of the Federal Food, Drug, and Cosmetic Act (FDCA); the Federal Anti-Tampering Act (FATA); and other statutes including applicable Title 18 violations; and to collect evidence to support successful prosecutive actions through the federal or state court systems as appropriate. OCI is responsible for all investigative related activities for the FDA.
Information is current as of February 12, 2013.
Fiscal Year - 2012
| Time | Target | Number |
|---|---|---|
| Oct 2011 | N/A | 27 |
| Nov 2011 | N/A | 26 |
| Dec 2011 | N/A | 29 |
| Jan 2012 | N/A | 19 |
| Feb 2012 | N/A | 16 |
| Mar 2012 | N/A | 26 |
| Apr 2012 | N/A | 17 |
| May 2012 | N/A | 21 |
| Jun 2012 | N/A | 19 |
| Jul 2012 | N/A | 23 |
| Aug 2012 | N/A | 30 |
| Sep 2012 | N/A | 15 |
FY 2012 YTD: 268
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.
